Optimizing antiretroviral therapy (ART) for maternal and child health (MCH): Rationale and design of the MCH-ART study

Journal of Acquired Immune Deficiency Syndromes

Volumn 72, Issue , 2016, Pages S189-S196

  Myer, Landon ^a   Phillips, Tamsin K ^a   Zerbe, Allison ^b   Ronan, Agnes ^a   Hsiao, Nei Yuan ^c   Mellins, Claude A ^d   Remien, Robert H ^d   Roux, Stanzi M Le ^a   Brittain, Kirsty ^a   Ciaranello, Andrea ^e   Petro, Greg ^a   McIntyre, James A ^a,f   Abrams, Elaine J ^b,g  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Department of Medicine   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f ANOVA HEALTH INSTITUTE   (South Africa)

^g NONE   (United States)

Author keywords

Adherence; Antiretroviral therapy; HIV; Integration; PMTCT; Retention

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION PREVENTION; MATERNAL CHILD HEALTH CARE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; VERTICAL TRANSMISSION; AFRICA SOUTH OF THE SAHARA; BREAST FEEDING; CLINICAL STUDY; CROSS-SECTIONAL STUDY; NEWBORN; PATIENT COMPLIANCE; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PUERPERIUM;

AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; BREAST FEEDING; CLINICAL STUDIES AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PATIENT COMPLIANCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84978818673     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001056     Document Type: Article

References (26)

1. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362: 2282-2294.
2. Chasela CS, Hudgens MG, Jamieson DJ, et al; BAN Study Group. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362:2271-2281.
3. Coovadia HM, Brown ER, Fowler MG, et al; HPTN 046 protocol team. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;379:221-228.
4. Abrams EJ, Myer L. Can we achieve an AIDS-free generation? Perspectives on the global campaign to eliminate new pediatric HIV infections. J Acquir Immune Defic Syndr. 2013;63(suppl 2):S208-S212.
5. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91:70-74.
6. Chi BH, Stringer JS, Moodley D. Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa. Curr HIV/AIDS Rep. 2013;10: 124-133.
7. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS. 2013; 8:474-489.
8. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26:2039-2052.
9. Ngarina M, Popenoe R, Kilewo C, et al. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania. BMC Public Health. 2013;13:450.
10. Shaffer N, Abrams EJ, Becquet R. Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS 2014;28:599-601.
11. Phillips T, Thebus E, Bekker LG, et al. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. J Int AIDS Soc. 2014;17:19242.
12. Gourlay A, Birdthistle I, Mburu G, et al. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16:18588.
13. Myer L, Phillips T, Manuelli V, et al. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2015;69:e57-65.
14. Phillips T, McNairy ML, Zerbe A, et al. Implementation and operational research: postpartum transfer of care among HIV-infected women initiating antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr. 2015;70:e102-e109.
15. Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS. 2013;8:498-503.
16. Bhardwaj S, Carter B, Aarons GA, et al. Implementation research for the prevention of mother-to-child HIV transmission in sub-Saharan Africa: existing evidence, current gaps, and new opportunities. Curr HIV/AIDS Rep. 2015;12:246-255.
17. Ewart CK. Social action theory for a public health psychology. Am Psychol. 1991;46:931-946.
18. Ciaranello AL, Myer L, Kelly K, et al. Point-of-care CD4 testing to inform selection of antiretroviral medications in South African antenatal clinics: a cost-effectiveness analysis. PLoS One. 2015;10:e0117751.
19. Ciaranello AL, Perez F, Engelsmann B, et al. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013;56: 430-446.
20. Grimsrud A, Sharp J, Kalombo C, et al. Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. J Int AIDS Soc. 2015;18:19984.
21. Myer L, Phillips TK, Hsiao NY, et al. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa. J Int AIDS Soc. 2015;18:20045.
22. Phillips T, Zerbe A, McIntyre JA, et al. Pregnancy Intentions Among HIV-infected Women Seeking Antenatal Care in Cape Town South Africa. 21st Conference on Retroviruses and Opportunistic Infections. Boston, MA; 2014.
23. Bernstein M, Phillips T, Zerbe A, et al. Intimate Partner Violence Among HIV-infected Pregnant Women Initiating Antiretroviral Therapy in South Africa. Poster MoPeb192. 8th International Conference on HIV Pathogenesis, Treatment and Prevention. Vancouver, Canada; 2015.
24. Wong M, Myer L, Zerbe A, et al. Psychosocial Factors in Younger versus Older HIV-infected Pregnant Women Initiating Antiretroviral Therapy in Cape Town, South Africa. Abstract 16. 7th International Workshop on HIV Pediatrics. Vancouver, Canada; 2015.
25. Myer L, Phillips T, McIntyre J, et al. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa. HIV Med. In press.
26. Phillips T, Zerbe A, Ronan A, et al. Side Effects and Treatment Adherence after ART Initiation in Pregnancy in South Africa. 22nd Conference on Retroviruses and Opportunistic Infections. Seattle, WA; 2015.